chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Agitation, Blood culture negative, Blood gases
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pH decreased, COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Chronic respiratory failure
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Confusional state, Drug screen positive, Endotracheal intubation, Hypotension
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Intensive care, Lactic acidosis, Leukocytosis, Lung disorder
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Miosis, PCO2 increased, PO2 increased, PaO2/FiO2 ratio, Pneumonia
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Polyuria, Positive airway pressure therapy, Respiratory failure, Restlessness, SARS-CoV-2 test positive
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Sepsis, Toxic encephalopathy, Unresponsive to stimuli
Clinical narrative: Patient was found unresponsive with pinpoint pupils in the hotel room. She was given intranasal and intravenous naloxone improvement in mentation but reportedly hypoxic with SpO2 in 80s patient placed on non-rebreather mask switched to BiPAP but agitated restless required intubation in the emergency department.  Initial ABGs pH 7.19 PO2 236 PC O2 67 PF ratio 236 .SARs Cov2 screen positive.  Chest x-ray bibasilar airspace disease.  UDS positive for cannabis.  Patient admitted to ICU on 02/10/2022 with acute hypoxic hypercapnic respiratory failure, pneumonia, acute toxic metabolic encephalopathy acute kidney injury and lactic acidosis. Patient required vasopressors for hypotension in ICU 2/11 patient extubated.  BiPAP 2/12 patient restless agitated-olanzapine p.r.n. added taken off BiPAP placed on high-flow nasal cannula.  Requires intermittent diuresis with Lasix.percedex drip weaned off 2/13-oxygen wean to nasal cannula. Patient restarted on Toprol-XL and spironolactone and received Lasix 40 mg x1.  Tolerated p.o. Transferred out of ICU 2/13    Patient required high-flow nasal cannula 2/14 night shift but able to be weaned to nasal cannula  6 L.  Patient started on barcitinib  by Infectious Disease 2/14. Continues on Decadron. Oxygen wean to nasal cannula 4 L on 02/16. Oxygen wean to 2 L on 2/18  Discharge on oxygen 1 L nasal cannula  Discharge Diagnoses:  Acute respiratory failure with hypoxia and hypercapnia -extubated 2/11 COVID-19 Acute COPD exacerbation-  Improved  Chronic hypoxic respiratory failure-on 2L home oxygen at baseline "as needed" Leucocytosis- likely secondary to steroids- better  - Weaned off to room air earlier - started on Decadron 2/ 13 transition from IV Solu-Medrol,Baricitinib since 2/14.  Completed Decadron total 10 days. Appreciate Infectious Disease input - Continue Nocturnal BiPAP/CPAP.Known sleep apnea- Recommended outpatient sleep study .  Patient reports intolerance to CPAP device 2 years ago. Pulmonary toileting - wean oxygen as able - DC baricitinib on discharge    Severe sepsis on admission with probable pneumonia - Blood culture Neg.  Ceftriaxone and doxycycline for total 5 days.  Completed course of antibiotics   Acute toxic metabolic encephalopathy resolved, with Agitation confusion restlessness in ICU - secondary to above improved - On  bupropion Depakote, Effexor and trazodone .Patient tolerating medication without excessive somnolence
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lip blister, Oral herpes
Clinical narrative: As with every vaccine and booster I have received (total of 5 doses), I developed a severe fever blister on my lip within 3 weeks of having the injection.  Prior to receiving these vaccines, I rarely experienced these outbreaks.  I have reported each outbreak I have experienced through VAERS.  Over the past 8 mnths, I have taken valacyclovir to limit the number of blisters.  Unfortunately, I stopped taking the medication 2 months ago.  After the fever blister formed yesterday, I began taking 500 mg valacyclovir again to lessen the severity.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: pediatric moderna booster administer instead of adult  moderna bivalent boost. no adverse event. patient and dr being notified. patient being called back in to be administered adult  bivalent moderna booster
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event reported by patient.  We received communication from home office that although vaccine had expired (we were using the beyond use date from when we received product) that revaccination was not necessary.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC BOOSTER ADMINISTERED INSTEAD OF ADULT BOOSTER. PATIENT & DR BEING NOTIFIED. PATIENT WILL RETURN FOR ADULT BOOSTER.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction reported by customer.  We received communication from our home office that although dose was expired (as we were going by the beyond use date from when we received the inventory) that it was determined that the vaccine was in fact still viable at the time of administration- and that revaccination was not needed.
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC BIVALENT MODERNA BOOSTER ADMINISTERED INSTEAD OF ADULT.
Age: 12.0
Sex: M
Vaccine: FLUA4, HPV9, FLUC3, HPV9
Symptoms: Syncope
Clinical narrative: Syncope 5 1/2 hours after receiving
Age: 12.0
Sex: M
Vaccine: FLUA4, HPV9, FLUC3, HPV9
Symptoms: Electrocardiogram, Syncope
Clinical narrative: Syncope 5 1/2 hours after receiving
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Myalgia, Oropharyngeal pain
Clinical narrative: I had mild sore throat, congested cough, fatigue, muscle aches are pretty much all I had for my symptoms of COVID. I started on Paxlovid for COVID.  I am currently testing negative.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion
Clinical narrative: I had mild sore throat, congested cough, fatigue, muscle aches are pretty much all I had for my symptoms of COVID. I started on Paxlovid for COVID.  I am currently testing negative.
Age: 6.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Mother had signed consent for child to receive flu shot.  Afterward, it was noticed that she had taken him to another pediatrician for a flu shot on 10/14/22.  Child was monitored.  No adverse reactions.
Age: 23.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC MODERNA BIVALENT BOOSTER ADMINISTERED TO ADULT
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypertension, Pyrexia
Clinical narrative: Resident became hypertensive, had fever, short of breath.  Was sent to hospital due to symptoms and admitted.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC MODERNA BIVALENT BOOSTER ADMINISTERED TO ADULT
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Condition aggravated, Nasal congestion, Nasopharyngitis, Nausea
Clinical narrative: I contracted COVID-19.  I had nasal congestion, nausea, and a possible low fever. I also felt like I had a cold. I took Dayquil, Nyquil, Augmentin, and cough medicine for several days. Moreover, the mucus issues that I have been dealing with for the past few months also worsened after contracting COVID-19.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Secretion discharge
Clinical narrative: I contracted COVID-19.  I had nasal congestion, nausea, and a possible low fever. I also felt like I had a cold. I took Dayquil, Nyquil, Augmentin, and cough medicine for several days. Moreover, the mucus issues that I have been dealing with for the past few months also worsened after contracting COVID-19.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC MODERNA BIVALENT BOOSTER ADMINISTERED TO ADULT
Age: 25.0
Sex: F
Vaccine: FLUC4
Symptoms: Vaccination site erythema, Vaccination site irritation, Vaccination site swelling
Clinical narrative: Vaccination site started to become red, swollen, and irritated Told patient to take a benadryl and ice the area. If no improvement, or worsening symptoms by end of day today, seek medical care.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Headache, Pain, Pyrexia
Clinical narrative: I had a massive headache down the back of my head it felt like it was going to explode, I had Fever, Chilling, Body Aches. I treated myself with Nyquil, Dayquil, Mucinex, Chewable Elderberries Zinc and Vitamin C.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a massive headache down the back of my head it felt like it was going to explode, I had Fever, Chilling, Body Aches. I treated myself with Nyquil, Dayquil, Mucinex, Chewable Elderberries Zinc and Vitamin C.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Immunisation reaction, Pain, Pyrexia, Urticaria
Clinical narrative: Primary concern: broke out in extensive hives over torso, legs, and arms Also had: Fever of 100.4 or higher (may have been 101.4) Substantial fatigue and body aches  Went to Dr for hives, dr determined it was likely a vaccine reaction die to vaccine having occurred just prior to reaction.
Age: 52.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood potassium decreased, Blood sodium normal, Echocardiogram normal
Clinical narrative: She went into SVT the next day and required adenosine and was started on a beta blocker.  Holter monitor was ordered and referred to cardiology.
Age: 52.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Electrocardiogram ambulatory normal, Hypokalaemia, Hyponatraemia, Laboratory test abnormal, Supraventricular tachycardia
Clinical narrative: She went into SVT the next day and required adenosine and was started on a beta blocker.  Holter monitor was ordered and referred to cardiology.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram, Balance disorder, Cerebrovascular accident, Hemiparesis, Mobility decreased
Clinical narrative: Occlusion of right vertebral artery, stroke.  Symptoms began the morning of October 16, went to hospital via ambulance, discharged to home on the 18th, though medical team wanted in patient rehab. Now homebound with severely compromised mobility, right sided weakness, pain , balance issues
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Vertebral artery occlusion
Clinical narrative: Occlusion of right vertebral artery, stroke.  Symptoms began the morning of October 16, went to hospital via ambulance, discharged to home on the 18th, though medical team wanted in patient rehab. Now homebound with severely compromised mobility, right sided weakness, pain , balance issues
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Recalled product administered
Clinical narrative: There was no actual adverse event but the product was recalled on 10/12/2022 due to a short date from the manufacturer. Therefore, a VAERs must be completed as the vaccine was given after the 09/30/2022 date.
Age: 44.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC BIVALENT MODERNA BOOSTER ADMINISTERED TO ADULT
Age: 70.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Fatigue, Muscle tightness, Osteoarthritis, Pain, Pain in extremity
Clinical narrative: It started on the next day with the usual aches and tiredness. The next day I noticed that all my muscles were still tight especially in my hip and quads area. It continued to get worse to get worse to where I was not able to do my physical therapy or the walks. It truly hurt. It was a 6 or 7 on a scale of 1-10. I took heavy dose of ibuprofen, but the pain continued. Friday was the worse. I went to the doctor, and he told me to go back and start the physical therapy again and to gradually start walking. He also advised me to continue to take the ibuprofen for pain. My pain is about a 2 in my quads and I walked this morning for a short period, so the symptoms are not gone but are getting better.
Age: 70.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: X-ray of pelvis and hip abnormal
Clinical narrative: It started on the next day with the usual aches and tiredness. The next day I noticed that all my muscles were still tight especially in my hip and quads area. It continued to get worse to get worse to where I was not able to do my physical therapy or the walks. It truly hurt. It was a 6 or 7 on a scale of 1-10. I took heavy dose of ibuprofen, but the pain continued. Friday was the worse. I went to the doctor, and he told me to go back and start the physical therapy again and to gradually start walking. He also advised me to continue to take the ibuprofen for pain. My pain is about a 2 in my quads and I walked this morning for a short period, so the symptoms are not gone but are getting better.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Gastrointestinal disorder, Impaired work ability, Nasopharyngitis, Respiratory tract congestion
Clinical narrative: I had a stomach thing one morning. Then, I had a tickle in my throat like before you get a cold. Then, I got a head cold but it wasn't bad so I went to work. I thought I should get tested after work and I did. I tested positive for COVID-19.  I really don't feel bad at all. If I didn't get tested, I would be at work right now. I don't have a headache or fever and I feel like I could go for a walk today. I just have a tiny bit of congestion. I did not lose smell or taste so far.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I had a stomach thing one morning. Then, I had a tickle in my throat like before you get a cold. Then, I got a head cold but it wasn't bad so I went to work. I thought I should get tested after work and I did. I tested positive for COVID-19.  I really don't feel bad at all. If I didn't get tested, I would be at work right now. I don't have a headache or fever and I feel like I could go for a walk today. I just have a tiny bit of congestion. I did not lose smell or taste so far.
Age: 79.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Rash, Rash pruritic, Varicella zoster virus infection
Clinical narrative: 2 days after vaccine the patient developed a rash which was itchy and then painful.  On evaluation in clinic the rash was consistent with varicella zoster.  Notably she has had both of her shingrix vaccines.
Age: 65.0
Sex: M
Vaccine: COVID19, TDAP
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient came into the clinic to receive the Moderna Bivalent but was inadvertently  given the Moderna pediatric 0.5 mL dose. KDHE, CDC and Moderna Helpline were notified this same day for guidance. Patient was notified same day of the  error.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose, Wrong product administered
Clinical narrative: Patient came into the clinic to receive the Moderna Bivalent but was inadvertently given the Moderna pediatric 0.5 mL dose. Agency, CDC and Moderna Helpline were notified this same day for guidance. Patient was notified same day of the  error.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient came into the clinic to receive the Moderna Bivalent but was inadvertently given the Moderna pediatric 0.5 mL dose. Health Department, CDC and Moderna Helpline were notified this same day for guidance. Patient was notified same day of the error.
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test, Condition aggravated, Faecal calprotectin, Gamma-glutamyltransferase decreased, Gastrointestinal pain
Clinical narrative: 24 hours after vaccination, flu-type symptoms that lasted 36 hours. 1 week later, increased GI pain that brought us to the ER then to a GI specialist.
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Influenza like illness, Stool analysis
Clinical narrative: 24 hours after vaccination, flu-type symptoms that lasted 36 hours. 1 week later, increased GI pain that brought us to the ER then to a GI specialist.
Age: 71.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Underdose, Wrong product administered
Clinical narrative: Patient came into the clinic to receive the Moderna Bivalent but was inadvertently given the Moderna pediatric 0.5 mL dose. Agency, CDC and Moderna Helpline were notified this same day for guidance. Patient was notified same day of the error.
Age: 51.0
Sex: M
Vaccine: FLU4
Symptoms: Erythema, Mechanical urticaria, Pruritus, Scratch
Clinical narrative: Patient received the flu vaccine at Employee Health by this writer as he does every year. This writer monitored him for 10-12 minutes with no reaction observed or reported. Patient returned less than 10 min after reporting feeling itchy on his upper extremities, scratching, leaving marks on his skin "dermatographia". Denied any difficulty breathing, no respiratory distress noted, no other symptoms reported other than itchiness. He reports he had this happened before for a while in the past year, but didn't know the cause. This writer offered Benadryl PO at that time, but he wanted to wait if it resolved on its own. The itchiness subsided and skin redness was gone within an hour without any antihistamines.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Sleep disorder
Clinical narrative: Extreme itching on soles of feet and palms of hands, only at night time, lasted for 18 days, interrupted sleep nightly, began taking Claritin at day 3, no topical or other antihistamines helped
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC MODERNA BIVALENT BOOSTER ADMINISTERED TO ADULT
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a pediatric vaccine that had the wrong expiration date  on the label but the actual expiration was 09/30/2022. They received the vaccine  on  10/02/2022. I have not heard any complaint from the parent
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Abdominal pain upper, Blood pressure increased, COVID-19, Cough, Diarrhoea
Clinical narrative: Tested positive for Covid on 10/03/2022, following severe GI distress. Diarrhea, severe stomach cramps, vomiting, nausea. The episode lasted for 2-3 hours and symptoms subsided. I had intermittent headache and post nasal drip with some coughing. I contacted my clinician and received and took a course of Paxlovid. On 10/11/2022 I tested negative for Covid, but had more severe headache and face pain, and sharply elevated blood pressure. I went to clinic, as diagnosed with sinusitis, prescribed Doxycycline Monohydrate. Returned on 10/20/22 and was prescribed Azelastine nasal spray. I completed 5 days of using Azelastine and today began using Flonase to deal with post nasal drip. Blood pressure is still elevated.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Facial pain, Gastrointestinal disorder, Headache, Nausea, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid on 10/03/2022, following severe GI distress. Diarrhea, severe stomach cramps, vomiting, nausea. The episode lasted for 2-3 hours and symptoms subsided. I had intermittent headache and post nasal drip with some coughing. I contacted my clinician and received and took a course of Paxlovid. On 10/11/2022 I tested negative for Covid, but had more severe headache and face pain, and sharply elevated blood pressure. I went to clinic, as diagnosed with sinusitis, prescribed Doxycycline Monohydrate. Returned on 10/20/22 and was prescribed Azelastine nasal spray. I completed 5 days of using Azelastine and today began using Flonase to deal with post nasal drip. Blood pressure is still elevated.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Sinusitis, Upper-airway cough syndrome, Vomiting
Clinical narrative: Tested positive for Covid on 10/03/2022, following severe GI distress. Diarrhea, severe stomach cramps, vomiting, nausea. The episode lasted for 2-3 hours and symptoms subsided. I had intermittent headache and post nasal drip with some coughing. I contacted my clinician and received and took a course of Paxlovid. On 10/11/2022 I tested negative for Covid, but had more severe headache and face pain, and sharply elevated blood pressure. I went to clinic, as diagnosed with sinusitis, prescribed Doxycycline Monohydrate. Returned on 10/20/22 and was prescribed Azelastine nasal spray. I completed 5 days of using Azelastine and today began using Flonase to deal with post nasal drip. Blood pressure is still elevated.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiac flutter, Dyspnoea exertional, Myalgia, Palpitations
Clinical narrative: muscle aches, shortness of breath with activivity, heart flutters & racing
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered doses of the affected lot after the Sept. 30 expiration date but on or before Oct. 19.  manufacturer data to support the stability and efficacy, revaccination is not indicated, and patient notification is not required. Any dose administered on or after Oct. 1 must be reported in SCRT and VAERS.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC MODERNA BIVALENT COVID BOOSTER ADMINISTERED TO ADULT
Age: 48.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Fatigue, General symptom, Joint swelling, Myalgia
Clinical narrative: I felt fine after the shot didn't have arm pain. I continued to feel fine that day and the next till approximately 20 hours post the shot. I started with a fever and general symptoms expected. I took a COVID-19 test and it was negative. 24 hours later my knees, ankles, elbows, back were painful and swelling. I did have muscle pain as well but this was actual joint pain. I've continued to have that. The fever had been on and off until 10/24. The fever wasn't high it was 99.9 the highest, and was upon exertion I was also fatigued. The joint problem isn't getting better but getting worse. I am waiting to try and get in to see a doctor at this point.
Age: 48.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: I felt fine after the shot didn't have arm pain. I continued to feel fine that day and the next till approximately 20 hours post the shot. I started with a fever and general symptoms expected. I took a COVID-19 test and it was negative. 24 hours later my knees, ankles, elbows, back were painful and swelling. I did have muscle pain as well but this was actual joint pain. I've continued to have that. The fever had been on and off until 10/24. The fever wasn't high it was 99.9 the highest, and was upon exertion I was also fatigued. The joint problem isn't getting better but getting worse. I am waiting to try and get in to see a doctor at this point.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Hypoxia, Pneumonia
Clinical narrative: COVID+ 10/16/2022 - Vaccination status - moderna x3 BRIEF OVERVIEW:  Admission Date: 10/16/2022 Discharge Date: Oct 21, 2022  Discharge Disposition:  home health care svc    Active Issues Requiring Follow-up:  - COVID: finish steroid course. Follow-up with PCP.    ?  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Pneumonia of right lung due to infectious organism, unspecified part of lung Pneumonia due to COVID-19 virus COVID-19   HOSPITAL COURSE: 75-year-old man with history of asthma, esophageal dysmotility with associated weight loss who was admitted with acute respiratory failure with hypoxemia secondary to COVID-19 pneumonia superimposed community-acquired pneumonia.  He was placed on empiric IV ceftriaxone and azithromycin as well as remdesivir and Decadron. Patient with improvement in respiratory status, weaned back to RA. Finished 5 day course of ceftriaxone and azithro for CAP coverage, as well as 5 day course of remdesivir for COVID. Patient had 5 days of steroids while inpatient, and discharged with 5 additional days to finish 10 day course. PT/OT evaluated patient and recommended skilled nursing, patient decline and wanted to be set up with HHC at assisted living facility. Patient medically stable for discharge home 10/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Superinfection
Clinical narrative: COVID+ 10/16/2022 - Vaccination status - moderna x3 BRIEF OVERVIEW:  Admission Date: 10/16/2022 Discharge Date: Oct 21, 2022  Discharge Disposition:  home health care svc    Active Issues Requiring Follow-up:  - COVID: finish steroid course. Follow-up with PCP.    ?  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Pneumonia of right lung due to infectious organism, unspecified part of lung Pneumonia due to COVID-19 virus COVID-19   HOSPITAL COURSE: 75-year-old man with history of asthma, esophageal dysmotility with associated weight loss who was admitted with acute respiratory failure with hypoxemia secondary to COVID-19 pneumonia superimposed community-acquired pneumonia.  He was placed on empiric IV ceftriaxone and azithromycin as well as remdesivir and Decadron. Patient with improvement in respiratory status, weaned back to RA. Finished 5 day course of ceftriaxone and azithro for CAP coverage, as well as 5 day course of remdesivir for COVID. Patient had 5 days of steroids while inpatient, and discharged with 5 additional days to finish 10 day course. PT/OT evaluated patient and recommended skilled nursing, patient decline and wanted to be set up with HHC at assisted living facility. Patient medically stable for discharge home 10/21.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered doses of the affected lot after the Sept. 30 expiration date but on or before Oct. 19.  manufacturer data to support the stability and efficacy, revaccination is not indicated, and patient notification is not required. Any dose administered on or after Oct. 1 must be reported in database and VAERS.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: The influenza vaccine Fluarix was administered after a temperature excursion that the vaccine was not viable.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC MODERNA BIVALENT COVID BOOSTER ADMINISTERED TO ADULT
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a Pediatric vaccine that had wrong expiration date on the label but the actual expiration date was 09/30/2022. They received the vaccine on 10/02/2022. I have not heard any complaint from the parent
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Back pain, Injection site reaction, Pain in extremity, Rash macular, Respiratory tract congestion
Clinical narrative: 15 minutes after injection reported and visualized Reddened, blotchy areas neck,  to injection site No dyspnea or throat swelling.  Given Benadryl 50mg po and advised to stay on site.   The next day 10/22 I received the following email, 11:16am Good morning  I woke up still with red splotches, congestion, and lower back pain. Arm is a little sore but that's expected.  I have taken 200 mg of Benadryl, steroids and Pepcid. Luckily still no trouble breathing at this point.   Thank you,
Age: 10.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Headache, Nausea, Pain, Product preparation error, Pyrexia
Clinical narrative: Child was given 0.2 ml of undiluted COVID vaccine.   Tolerated vaccine well.  Spoke with Step father on 10/25/22 who reports side effects of fever, nausea, body ached and headache within 8 hours of getting vaccine.  Symptoms improved by morning.
Age: 26.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: PEDIATRIC VACCONE ADMINISTERED TO ADULT
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Facial paralysis, Full blood count abnormal, Immunoglobulin therapy, Increased tendency to bruise, Platelet count decreased
Clinical narrative: Patient developed atypical facial paralysis in June 2022 and was treated initially with doxycycline by her lyme specialist. She developed side effects so then treated with cefuroxime. 10 days later she noted significant easy bruising and was found to have platelets of 8,000 8/5/22. Initially treated with dexamethasone 40 mg x4 days, IVIG and platelet transfusion.  Platelets later dropped again and had a second course of dexamethasone.  A third drop of platelets recently and patient is now s/p another course of IVIG, platelet transfusion and now on prednisone taper. Workup for viral illness, nutritional issues have been negative as had initial workup for rheumatologic etiologies but will be repeated as testing done while on steroids
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet transfusion, Viral test negative
Clinical narrative: Patient developed atypical facial paralysis in June 2022 and was treated initially with doxycycline by her lyme specialist. She developed side effects so then treated with cefuroxime. 10 days later she noted significant easy bruising and was found to have platelets of 8,000 8/5/22. Initially treated with dexamethasone 40 mg x4 days, IVIG and platelet transfusion.  Platelets later dropped again and had a second course of dexamethasone.  A third drop of platelets recently and patient is now s/p another course of IVIG, platelet transfusion and now on prednisone taper. Workup for viral illness, nutritional issues have been negative as had initial workup for rheumatologic etiologies but will be repeated as testing done while on steroids
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Pyrexia
Clinical narrative: 10/07/2022, I went to get my 4th Moderna dose. The next day, I had a low grade fever and felt flu-ish and a headache at the base of my skull. I took ibuprofen for over a week. I went to the doctor on 10/17/2022 and they gave me a muscle relaxant and a steroid pack. That helped.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Oropharyngeal pain, Pulmonary congestion
Clinical narrative: I got a sore throat on 10/19/22 and I knew I had been exposed to COVID-19 on 10/15/22. By 10/20/22 the sore throat was worse and I started getting the sniffles, but the home COVID-19 test was negative. By 10/21/22 I was much worse and the home COVID-19 test came back positive. Over the weekend I developed a cough, chest congestion but I did not have a fever, violent sneezes. By Monday 10/24/22 my symptoms started to get less and as of today 10/26/22 I still have an occasional cough and runny nose. The doctor and I discussed medication but since my symptoms were mild we both felt it best that we let my body beat COVID-19.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I got a sore throat on 10/19/22 and I knew I had been exposed to COVID-19 on 10/15/22. By 10/20/22 the sore throat was worse and I started getting the sniffles, but the home COVID-19 test was negative. By 10/21/22 I was much worse and the home COVID-19 test came back positive. Over the weekend I developed a cough, chest congestion but I did not have a fever, violent sneezes. By Monday 10/24/22 my symptoms started to get less and as of today 10/26/22 I still have an occasional cough and runny nose. The doctor and I discussed medication but since my symptoms were mild we both felt it best that we let my body beat COVID-19.
Age: 83.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Blood test, COVID-19, Computerised tomogram thorax abnormal, Cough, Exposure to SARS-CoV-2
Clinical narrative: I was traveling out of state and returned on 10/17/2022. That night I ended up in the hospital with fluid on my heart. I was admitted in the hospital for 3 days. I am diabetic and have been on a very low salt diet, but while traveling, I was unable to abide by that diet. While in the hospital they treated me with LAsix and insulin and informed me that they thought my issue was due to my poor diet and lack of activity while traveling. They didn't test me for COVID-19 in the hospital. On Friday, I was informed that a friend tested positive for COVID-19. So, I tested myself and was also positive. I tested again on Sunday and was still positive. I had a little bit of stuffiness on Friday and had a bit of an irritated cough but no fever or loss of appetite or senses. By Sunday, when I woke up, even those symptoms were gone. Now, I am only experiencing an occasional cough, but even that is almost nonexistent. Everything was so mild; it didn't even feel like a cold.